Zobrazeno 1 - 10
of 82
pro vyhledávání: '"L G, Raisz"'
Autor:
L. G. Raisz
Publikováno v:
The Aging Male. 2:223-227
Osteoporosis is a major health concern in aging men. The risk of osteoporotic fracture, particularly of the hip, is increasing in men as life expectancy increases, and the health and economic costs in the future will be high. Research on the pathogen
Autor:
L. G. Raisz
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 81:37-43
Autor:
L. G. Raisz
Publikováno v:
Journal of Clinical Investigation. 111:945-947
Autor:
L. G. Raisz
Publikováno v:
Molecular Endocrinology. 7:17-22
Publikováno v:
The Journal of Immunology. 146:2633-2638
We investigated the effects that the combination of IL-1 alpha and transforming growth factor-beta (TGF-beta) had on PGE2 production in a murine clonal osteoblastic cell line MC3T3-E1 and primary rat calvarial osteoblast-like cells. In serum-suppleme
Publikováno v:
The Journal of Immunology. 145:4181-4184
Inhibitory factors towards IL-1 have been identified in the urine and in the supernatants of human monocyte cultures and have been shown to act as receptor antagonists. We have investigated whether a natural inhibitor purified from human urine (uIL-1
Autor:
L G, Raisz
Publikováno v:
Reviews in endocrinemetabolic disorders. 2(1)
Publikováno v:
The Journal of clinical endocrinology and metabolism. 86(6)
There is evidence that estrogen decreases bone turnover in men as well as women. We therefore hypothesized that older men would show increased bone resorption in response to inhibition of the aromatase enzyme, which converts androgens to estrogen. Fi
Autor:
P E, Lipsky, S B, Abramson, F C, Breedveld, P, Brook, R, Burmester, F, Buttgereit, G W, Cannon, F, Catella-Lawson, L J, Crofford, M, Doherty, M, Dougados, R N, DuBois, J, Froelich, L A, Garcia Rodriguez, A, Gibofsky, S, Hernandez-Diaz, M C, Hochberg, A, Krause, M H, Liang, K, Machold, P M, Peloso, L G, Raisz, B, Schayes, J M, Scheiman, L S, Simon, J, Smolen
Publikováno v:
The Journal of rheumatology. 27(6)
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(6)
Raloxifene HCl, a selective estrogen receptor modulator, has been shown to increase bone mineral density (BMD) and decrease biochemical markers of bone turnover in postmenopausal women without stimulatory effects on the breast and uterus. However, it